Cargando…
Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment
Cellular dormancy is defined as a state in which cells enter quiescence driven by intrinsic or extrinsic factors, and striking parallels exist between the concept of cellular dormancy in malignancies and the cancer stem cell theory. We showed now that the proven dormancy markers insulin-like growth...
Autores principales: | Adamski, Vivian, Hempelmann, Annika, Flüh, Charlotte, Lucius, Ralph, Synowitz, Michael, Hattermann, Kirsten, Held-Feindt, Janka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746126/ https://www.ncbi.nlm.nih.gov/pubmed/29296224 http://dx.doi.org/10.18632/oncotarget.22514 |
Ejemplares similares
-
Modeling treatment-dependent glioma growth including a dormant tumor cell subpopulation
por: Böttcher, Marvin A., et al.
Publicado: (2018) -
Isolation and Characterization of Fast-Migrating Human Glioma Cells in the Progression of Malignant Gliomas
por: Adamski, Vivian, et al.
Publicado: (2017) -
Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1
por: Adamski, Vivian, et al.
Publicado: (2020) -
The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16
por: Adamski, Vivian, et al.
Publicado: (2017) -
AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy
por: Flak, Dorota K, et al.
Publicado: (2020)